Dr. Reddy's Laboratories Ltd had earlier announced regarding the audit of its API manufacturing plant at Middleburg, New York. The company has received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit and the inspection classification of this facility is determined as 'Voluntary action indicated' (VAI). Currently, the company does not have any sales from this plant.
Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 4366.50 as compared to the previous close of Rs. 4320.25. The total number of shares traded during the day was 8364 in over 1178 trades.
The stock hit an intraday high of Rs. 4393.55 and intraday low of 4313.30. The net turnover during the day was Rs. 36481191.00.